News related to Afinitor (Everolimus) and/or conditions it is approved for
FDA OKs New Kids' Dose of Cancer Drug
Source: MedPage Today Product Alert [2012.08.30]
WASHINGTON -- The FDA has approved a pediatric dosage of the cancer drug everolimus (Afinitor Disperz) for the treatment of a rare brain tumor.
Anti-cancer drug, CB-839, in combination with everolimus, stops tumours growing in patients with advanced kidney cancer
Source: Cancer / Oncology News From Medical News Today [2016.11.30]
The first drug to target a key enzyme that cancer cells need to keep them alive has shown that it is effective in controlling disease in patients with advanced kidney cancer when it is used in...